Pascolizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Pascolizumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target IL-4
Clinical data
Legal status ?
Identifiers
CAS number 331243-22-2 N
ATC code None
UNII N1IOA09R6A YesY
Chemical data
Formula ?
 N (what is this?)  (verify)

Pascolizumab is a humanized monoclonal antibody for the treatment of asthma.[1] A Phase II clinical trial in patients with symptomatic glucocorticoid naive asthma has been conducted in 2001/2002.[2]

References[edit]

  1. ^ Hart, TK; Blackburn, MN; Brigham-Burke, M; Dede, K; Al-Mahdi, N; Zia-Amirhosseini, P; Cook, RM (2002). "Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma". Clinical and experimental immunology 130 (1): 93–100. doi:10.1046/j.1365-2249.2002.01973.x. PMC 1906490. PMID 12296858. 
  2. ^ ClinicalTrials.gov